Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Solid Tumor × Blood Specimen Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 47 Neoplasms 45 Colorectal Neoplasms 22 Prostatic Neoplasms 20 Lung Neoplasms 18 Pancreatic Neoplasms 16 Head and Neck Neoplasms 16 Neoplastic Cells, Circulating 15 Carcinoma, Non-Small-Cell Lung 14 Melanoma 12 Esophageal Neoplasms 10 Carcinoma, Hepatocellular 10 Ovarian Neoplasms 9 Colonic Neoplasms 9 Uterine Cervical Neoplasms 8 Liver Neoplasms 8 Glioma 8 Neoplasm Metastasis 7 Leukemia, Myeloid, Acute 7 Endometrial Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm, Residual 6 Myeloproliferative Disorders 6 Multiple Myeloma 6 Carcinoma, Renal Cell 6 Stomach Neoplasms 5 Sarcoma 5 Obesity 5 Myelodysplastic Syndromes 5 Leukemia 5

Interventions

Fluorodeoxyglucose F18 3 trifluridine tipiracil drug combination 1 tegafur-gimeracil-oteracil 1 Tegafur 1 Surveys and Questionnaires 1 Specimen Handling 1 S 1 (combination) 1 Radiomics 1 Proton Therapy 1 Postmortem Imaging 1 PMEPA1 protein, human 1 Off-Label Use 1 Latent Class Analysis 1 Immunohistochemistry 1 Hepatitis B Vaccines 1 Fluorouracil 1 Capecitabine 1 Blood Specimen Collection 1 Blood Component Removal 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07137312 2025-12-23

Ex Vivo Expansion (ACT-X)

Mayo Clinic

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡